Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
Vascular thrombosis and pregnancy morbidity represent the clinical manifestations of antiphospholipid syndrome (APS), which is serologically characterized by the persistent positivity of antiphospholipid antibodies (aPL). Antiplatelet and anticoagulant agents currently provide the mainstay of APS tr...
Saved in:
| Main Authors: | Cecilia Beatrice Chighizola, Tania Ubiali, Pier Luigi Meroni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2015/951424 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombotic antiphospholipid syndrome: Recurrent thromboses
by: Tatiana M. Reshetnyak, et al.
Published: (2024-09-01) -
Unresolved issues in the diagnosis and management of thrombotic antiphospholipid syndrome
by: Deepa J. Arachchillage, et al.
Published: (2025-02-01) -
Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
by: Angela Tincani, et al.
Published: (2019-06-01) -
PO64 | A silent hemorrhage in the immuno-thrombotic chaos of antiphospholipid syndrome
Published: (2025-08-01) -
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications
by: Tommaso Bucci, et al.
Published: (2025-02-01)